Cannabis Companies Push F.D.A. to Ease Rules on CBD Products (Published 2019) - The New York Times
Cannabis Companies Push F.D.A. to Ease Rules on CBD Products (Published 2019) The New York Times
News Wire
LIVEReal-time CBD & hemp news from 16+ industry sources. Updated every 2 hours.
559 stories6 sources
At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise - statnews.com
At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise statnews.com
FDA to hold its first hearing on CBD as industry leaders and experts demand action - NBC News
FDA to hold its first hearing on CBD as industry leaders and experts demand action NBC News
TSA updates 'medical marijuana' regulations to reflect FDA-approved drug containing cannabidiol - Fox News
TSA updates 'medical marijuana' regulations to reflect FDA-approved drug containing cannabidiol Fox News
Dude, where's my regulatory framework? As CBD gains popularity, Washington struggles to keep up - statnews.com
Dude, where's my regulatory framework? As CBD gains popularity, Washington struggles to keep up statnews.com
Can CBD Really Do All That? (Published 2019) - The New York Times
Can CBD Really Do All That? (Published 2019) The New York Times
CBD: What You Need to Know Before You Try - Cedars-Sinai
CBD: What You Need to Know Before You Try Cedars-Sinai
The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling (P5.5-007) - Neurology® Journals
The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling (P5.5-007) Ne...
The ABCs of CBD: Separating fact from fiction - NIH MedlinePlus Magazine (.gov)
The ABCs of CBD: Separating fact from fiction NIH MedlinePlus Magazine (.gov)
FDA Tells CBD Companies: Stop Making ‘Unfounded’ Claims about CBD Products - U.S. News & World Report
FDA Tells CBD Companies: Stop Making ‘Unfounded’ Claims about CBD Products U.S. News & World Report
FDA sets first hearing on CBD in May as the agency looks at legalizing the cannabis compound in food and drinks - CNBC
FDA sets first hearing on CBD in May as the agency looks at legalizing the cannabis compound in food and drinks CNBC
FDA Silent on CBD Regulation at Cosmetics Conference, But Legislation May Be Imminent - Mintz
FDA Silent on CBD Regulation at Cosmetics Conference, But Legislation May Be Imminent Mintz
Flood of products containing marijuana extract puts FDA in a bind - Politico
Flood of products containing marijuana extract puts FDA in a bind Politico
The cannabis industry is begging the FDA for some CBD regulations as Gottlieb heads to the Hill - CNBC
The cannabis industry is begging the FDA for some CBD regulations as Gottlieb heads to the Hill CNBC
NC Regulators To Begin Cracking Down On CBD-Infused Products - wfmynews2.com
NC Regulators To Begin Cracking Down On CBD-Infused Products wfmynews2.com
There’s a New Sheriff in Town: The Food and Drug Administration’s Move to Regulate CBD - Ward and Smith, P.A.
There’s a New Sheriff in Town: The Food and Drug Administration’s Move to Regulate CBD Ward and Smith, P.A.
What are FDA’s next regulatory steps on CBD and hemp? - Food Dive
What are FDA’s next regulatory steps on CBD and hemp? Food Dive
FDA weighs legalizing interstate sales of cannabis-based CBD in food and drinks - CNBC
FDA weighs legalizing interstate sales of cannabis-based CBD in food and drinks CNBC
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial - Psychiatry Online
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial Psychiatry Online
Showing 541–559 of 559 stories from News